August 22, 2017 3:27 PM ET

Healthcare Equipment and Supplies

Company Overview of NeoChord, Inc.

Company Overview

NeoChord, Inc., a medical device company, develops devices to treat mitral regurgitation. The company offers NeoChord, a disposable device that replaces damaged chordae through a small incision while the heart is beating. Its products are used to treat patients in TACT registry and non-registry centers in Europe. The company was founded in 2007 and is based in St. Louis Park, Minnesota.

5402 Parkdale Drive

Suite 160

St. Louis Park, MN 55416

United States

Founded in 2007

Phone:

952-698-7800

Fax:

952-467-6077

Key Executives for NeoChord, Inc.

Chief Executive Officer and President
Age: 50
Chief Financial Officer
Chief Medical Officer
Director of Quality
Vice President of Clinical Affairs, Regulatory and Quality
Age: 58
Compensation as of Fiscal Year 2017.

NeoChord, Inc. Key Developments

NeoChord, Inc. Announces Executive Changes

NeoChord, Inc. appointed Andrew ElBardissi as M.D. to its Board of Directors. ElBardissi is replacing Avi Kometz, MD as the representative from Deerfield Management on the NeoChord Board of Directors. ElBardissi has significant investment experience in the healthcare sector. He is currently an investor on the Private Transactions team at Deerfield Management Company and has previously held roles as an early stage life-sciences venture investor and investment banker.

NeoChord, Inc. Names J. Alex Martin Chairman of the Board

NeoChord, Inc. announced the appointment of J. Alex Martin, who currently serves as a director on the company’s Board, as Board Chairman, effective immediately.  Michael Fulton, M.D., the Company’s current Board Chairman, will remain as an integral member of the Board of Directors. Mr. Martin has significant corporate executive of the healthcare and medical device industries experience. He previously served as the President and CEO of Coherex Medical, where he led the company to a successful exit with Biosense Webster, a Johnson and Johnson company, in November 2015. Prior to Coherex, Mr. Martin was the President and CEO of WorldHeart Corporation, where he led the company to a successful exit with HeartWare in August 2012. Previously, Mr. Martin has held senior leadership roles with Edwards Lifesciences, Cordis Corporation, a Johnson & Johnson Company, and SonaMed Corporation.

NeoChord, Inc. Presents at 2016 Canaccord Genuity Medical Technology & Diagnostics Forum, Nov-17-2016 03:00 PM

NeoChord, Inc. Presents at 2016 Canaccord Genuity Medical Technology & Diagnostics Forum, Nov-17-2016 03:00 PM. Venue: Westin Grand Central, 212 East 42nd Street, New York, New York, United States.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NeoChord, Inc., please visit www.neochord.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.